Tannins as Hemostasis Modulators.

Area of Science:

• Phytochemistry
• Hemostasis Research
• Cardiovascular Pharmacology

Background:

• Cardiovascular diseases frequently impact the hemostasis system, leading to thromboembolic events.
• Plant-derived compounds, particularly tannins, are explored for their potential to modulate hemostasis and mitigate thromboembolism.
• Tannins, including ellagitannins, gallotannins, and procyanidins, are investigated for their hemostasis-modifying properties.

Purpose of the Study:

• To review the hemostasis-modifying abilities of ellagitannins, gallotannins, and procyanidins.
• To highlight the multifaceted effects of tannins on platelets, coagulation, fibrinolysis, and endothelium.
• To examine tannin activity under normal and pathological conditions, such as diabetes and hypercoagulation.

Main Methods:

• Literature review of studies investigating tannin effects on hemostasis components.
• Analysis of both beneficial and detrimental influences of tannins on the thrombotic process.
• Inclusion of studies conducted under various physiological and pathological conditions.

Main Results:

• Tannins exhibit multidirectional effects on the thrombotic process, influencing platelets, coagulation, fibrinolysis, and endothelium.
• The action of tannins is dependent on pathophysiology, with varied effects observed in conditions like diabetes.
• Most available data are derived from in vitro studies, indicating a need for further investigation.

Conclusions:

• Tannins possess significant potential for modulating the hemostasis system.
• Understanding the complex and sometimes opposing effects of tannins is crucial for therapeutic development.
• Further in vivo studies are essential to ascertain the actual efficacy and bioavailability of tannins in preventing thromboembolic events.